Replies to post #246 on Nordicus Partners Corp (NORD)

[e-ore]

I don't think they'll do that. ASNB is just going to require patience. There's so many good things going on there it will be noticed. Company management doesn't care about the stock price. It will move when investors realize the connection here,

http://www.the-wand.com/

and that this, from the last 10q, is just the beginning:

"Product sales of our biomaterials for the three months ended December 31, 2012 were $440,000 as compared with $179,000 for the prior year period, an increase of $261,000, or 145.8%. The increase is due to the growth in sales from existing and new customers."

This increase does not reflect sales of the-wand, imo. Assuming sales there take off in the future, this will be realized:

"Under the Agreement, Access Scientific will have exclusive rights to ChronoFlex C for use in midline catheters. A midline catheter is defined by the Centers for Disease Control and Epidemiology as between 3 and 8 inches in length. The newly announced agreement provides AdvanSource Biomaterials with a multi-year, multimillion-dollar opportunity based in part on advancing sales of The POWERWAND."

Market cap right now is $1 million. They are going to do more than twice that in revenue with profits this year. Worth at least 5 times what they're selling for now. Patience